DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

01011 NT PHARMA

Trading Add to Porfolio
Index Constituent : None
Major Shareholders Chin Yu (45.12%)
Ieong Iat (21.73%)
Ieong Chong Mang (8.15%)
Sector Health Care & Biotechnology
Web Site http://www.ntpharma.com Tel (852) 2808-1606
Email investorrelations@ntpharma.com Fax (852) 2508-9459
Related Equities N/A
Principal Activities The Group is mainly engaged in investment, research and development, manufacturing and sales of pharmaceutical products, as well as the provision of pharmaceutical marketing and promotion services.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
吳鐵 607,392,000(L)  37.81(L)  23/10/2018
錢余 607,392,000(L)  37.81(L)  23/10/2018
楊宗孟 265,660,500(L)  17.05(L)  25/10/2017
沈寧 265,660,500(L)  17.05(L)  25/10/2017
Haitong Securities Co., Ltd. 124,062,500(L)  7.72(L)  03/12/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
吳鐵 607,392,000(L)  37.81(L)  23/10/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top